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Neurobiology
Morphological and Functional Abnormalities in
Mitochondria Associated with Synaptic Degeneration
in Prion Disease
Zuzana Siskova´,* Don Joseph Mahad,†
Carianne Pudney,* Graham Campbell,†
Mark Cadogan,† Ayodeji Asuni, Vincent O’Connor,*
and Victor Hugh Perry
From the CNS Inflammation Group,* School of Biological
Sciences, University of Southampton, Southampton, United
Kingdom; and The Mitochondrial Research Group,† Newcastle
University, Newcastle, United Kingdom.
Synaptic and dendritic pathology is a well-docu-
mented component of prion disease. In commonwith
other neurodegenerative diseases that contain an el-
ement of protein misfolding, little is known about the
underlying mechanisms of synaptic degeneration. In
particular, in prion disease the relationship between
synaptic malfunction, degeneration, and mitochon-
dria has been neglected. We investigated a wide range
of mitochondrial parameters, including changes in
mitochondrial density, inner membrane ultrastruc-
ture, functional properties and nature of mitochon-
drial DNA from hippocampal tissue of mice with
prion disease, which have ongoing synaptic pathol-
ogy. Our results indicate that despite a lack of detectable
changes in either mitochondrial density or expression
of the mitochondrial proteins, mitochondrial function
was impaired when compared with age-matched con-
trol animals. We observed changes in mitochondrial
inner membrane morphology and a reduction in the
cytochrome c oxidase activity relative to a sustained
level of mitochondrial proteins such as porin and indi-
vidual, functionally important subunits of complex II
and complex IV. These data support the idea that
mitochondrial dysfunction appears to occur due to
inhibition or modification of respiratory complex
rather than deletions of mitochondrial DNA. In-
deed, these changes were seen in the stratum radia-
tum where synaptic pathology is readily detected,
indicating that mitochondrial function is impaired
and could potentially contribute to or even initiate the
synaptic pathology in prion disease. (Am J Pathol 2010,
177:1411–1421; DOI: 10.2353/ajpath.2010.091037)
Mitochondria are vital organelles in all eukaryotic cells
and are responsible for the efficient generation of high-
energy compounds such as ATP produced by oxidative-
phosphorylation system, also called the respiratory
chain. The mitochondrial respiratory chain is located in
the inner mitochondrial membrane and consists of five
complexes (complexes I–V), each consisting of multiple
subunits encoded by both nuclear and mitochondrial
DNA (mtDNA), except complex II or succinate dehydro-
genase (SDH) that is entirely encoded by nuclear DNA.1
Cytochrome c oxidase (COX) or complex IV is the final
component of the respiratory chain complex crucial for
ATP production and the site of the highest oxygen con-
sumption.2 Neuronal mitochondria display considerable
morphological uniformity particularly in terms of the fold-
ing of the energy-transducing inner membrane,3 which
forms numerous invaginations or cristae. Within the neu-
ron, the synaptic compartment is the site at which de-
mands on mitochondrial functions, such as energy sup-
ply and buffering of intracellular Ca2 are especially
significant.4,5 The interdependence of synaptic activity
and mitochondrial distribution has been described both
at the presynaptic6 and the postsynaptic elements of
dendritic spines of living hippocampal neurons.7
Several neurodegenerative diseases in which there is
accumulation of misfolded proteins, for example Alzhei-
mer’s disease and Parkinson’s disease,8–10 are associ-
ated with malfunction of both mitochondria and synaptic
compartments. Malfunctions of mitochondrial metabolism
that lead to reduced ATP production, impaired Ca2
buffering and generation of reactive oxygen species may
contribute to both aging and neurodegenerative dis-
ease.11 The inner-membrane structural alterations, in
particular numerous dilated or swollen cristae have been
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consistently implicated in processes associated with ap-
optosis and as a response to oxidative stress in various
neurodegenerative diseases.8,12
Prion diseases are fatal transmissible neurodegenera-
tive diseases that affect several species, including hu-
mans. The pathological features of prion diseases are
extensive neuronal loss, vacuolation, synaptic alterations,
and accumulation of a misfolded and protease-resistant
form of the prion protein, commonly termed PrPSc.13
There is evidence that in murine prion disease synaptic
and dendritic alterations precede neuronal death,14–18
however, the role of the mitochondria in these early syn-
aptic changes has not been investigated during disease
evolution.
We hypothesized that mitochondrial abnormalities
could accompany or perhaps contribute to early synaptic
changes in the ME7 model, a murine model that we have
previously characterized in some detail.15,17–18 In the
present study we demonstrate that the activity of respi-
ratory complex IV is significantly decreased in the hip-
pocampus of diseased animals. This contrasts with the
sustained expression of porin, a voltage-gated anion
channel located in the outer mitochondrial membrane
that is widely used as a mitochondrial marker, and sus-
tained expression of functionally important subunits of
complex IV and complex II. Further, morphometric data
suggest that mitochondrial numeric density remained un-
changed. Interestingly, these changes correlated both
temporally and spatially with early loss of Type I (exci-
tatory) synapses in the stratum radiatum. The role of
mitochondria is extensively studied as a primary cause
of neuronal cell death or as a secondary phenomenon
occurring on the way to neuronal death. The current
study used tractable, staged and well-characterized
prion pathology of the ME7 model that supports the
role of an early dysfunction, which thus could be a
contributor to disease progression rather than simply a
consequence.
Materials and Methods
Animals
C57BL/6J female mice ages 8 to 10 weeks were obtained
from Harlan Laboratories (Bicester, UK) and were group-
housed within the animal care facilities in the School of
Biological Sciences, University of Southampton as de-
scribed previously.18
Surgeries
All operations were performed under the UK Home Office
license, as described previously.18 Briefly, surgery was
performed when the mice were 11 to 12 weeks old. Mice
were anesthetized by intraperitoneal injection of Avertin
(2,2,2-tribromoethanol solution) (20 ml/kg) and mounted
in a stereotaxic frame (David Kopf Instruments, Tujunga,
CA). Injections of 1 l of homogenate (10% w/v in sterile
PBS) of either normal C57 mouse brain (NBH-animals) or
of a ME7 prion agent-infected brain (ME7-animals) were
made bilaterally into the dorsal hippocampus with a 10-l
Hamilton syringe. The suspension was slowly infused and
the needle was left in place for 2 minutes before being
slowly withdrawn. Mice were placed in a heated recovery
chamber and when fully recovered, rehoused in groups
and checked daily. Extracted tissue was analyzed using
various techniques as described below at early stages
(10 and 12 weeks p.i.) and at late stages (16, 18, and 20
weeks p.i.).
Electron Microscopy
Tissue Preparation
NBH- and ME7-animals were terminally anesthetized
with sodium pentobarbital and sacrificed by perfusion
fixation for transmission electron microscopy at 10, 12, 16
and 18 weeks post injection (p.i.) as described previ-
ously.18 A slow cardiac perfusion (20 to 30 minutes) was
performed with fixative containing 3.4% paraformalde-
hyde, 1.25% glutaraldehyde, and 0.2% picric acid in 0.1
mol/L sodium phosphate buffer (final pH 7.2 to 7.4) im-
mediately after short (1.5 minutes) perfusion with hep-
arinized saline, to minimize synaptic and glial ultrastruc-
tural changes that could be caused by brain hypoxia. The
optimal perfusion fixation protocol was established by
carefully monitoring ultrastructural preservation of synap-
tic vesicle integrity, post-synaptic density and mitochon-
drial ultrastructure in NBH- and naive animals to ensure
that the observed abnormalities are disease-associated.
After approximately 1 hour, the brains were dissected
and postfixed in fresh fixative overnight at 4°C, and 150
m thick coronal sections were cut on a vibrotome and
the area of CA1 pyramidal layer and stratum radiatum
was dissected out. Microdissected areas were washed in
0.1 mol/L sodium phosphate buffer and postfixed at room
temperature for 1 hour in 1% osmium tetroxide. Tissue
blocks were dehydrated at room temperature through
graded ethanols to 100% for 10 minutes each, including
1% uranyl acetate in 70% ethanol for 40 minutes. Blocks
were placed in acetonitrile for 10 minutes and overnight
in a 50:50 solution of acetonitrile:TAAB resin, subse-
quently infiltrated with fresh TAAB resin for 6 hours and
polymerized at 60°C for 20 to 24 hours. TAAB blocks
were hand trimmed, followed by glass trimming at room
temperature to a trapezoid containing CA1 pyramidal cell
bodies and dendritic arbor of stratum radiatum. Semithin
(0.5 to 1 m) sections were stained (1% v/v toluidine blue
in 1% w/v borax) and used to guide further cutting of the
specimen block to ultra-thin sections (60 to 70 nm).
Ultra-thin sections were placed either onto thin bar
mesh copper palladium grids or formvar-coated slot
grids and stained in Reynolds lead stain for 5 minutes.
The grids were then gently immersed three times in
distilled water and left to dry. Grids were examined
using a Hitachi H7000 transmission electron micro-
scope with a MegaView III digital camera (Soft Imaging
System) and subsequently processed using Adobe
Photoshop software.
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Electron Microscopy of Neuronal Mitochondria
within the Stratum Radiatum
Mitochondrial Area Measurements
Measurements were generated from transmission
electron microscopy images with a magnification of
20,000; images were taken from at least two sections of
a minimum of 10 sections apart within the tissue block
and were positioned to avoid blood vessels, occasional
areas of myelination, and the astroglial swelling to ensure
that predominantly, if not exclusively, neuronal mitochon-
dria were analyzed. ImageJ software was used to calcu-
late the area by drawing around of each individual mito-
chondrion analyzed. At least 100 measurements for each
animal were generated at 10 (n  6), 12 (n  3), 16 (n 
3), and 18 (n  3) weeks p.i. for both NBH- and
ME7-animals.
Mitochondrial Density Measurements
Measurements were generated from at least two im-
ages at magnification of 3000 taken from 2 sections at
least 10 sections apart within the tissue block from each
animal, every mitochondria visible by eye was marked
with a dot within a counting frame of 286 m2 positioned
to avoid blood vessels, occasional areas of myelination,
and the astroglial swelling. To ensure that only neuronal
mitochondria were included the defining ultrastructural
criteria used for identification of astrocytes and neuronal
cells were applied as described previously.18
Briefly, astrocytes in comparison with neurons are
characterized as cells whose cytoplasm is generally
electron lucent or pale. The most prominent cytoplasmic
component of the astrocyte is the numerous fibrils or
filaments that occur throughout the perikaryon and ex-
tend as parallel arrays into the processes, the filaments
are 8 to 9 nm in diameter (generally smaller than the
neurofilaments). In contrast to neurofilaments, they com-
monly occur in closely packed bundles. Another promi-
nent difference is the sparse presence of organelles in
the cytoplasm of astrocytes; the organelles are mainly
confined to the perikaryal region, the mitochondria are
generally elongated and in the processes they are usu-
ally oriented parallel to the long axes of the processes
and parallel to the filaments.
Quantification of Ultrastructural Defects
Quantification of mitochondrial ultrastructural defects
was performed from identical images used for the area
measurements as indicated above. Every mitochondria
of neuronal origin was analyzed and based on its ultra-
structural appearance classified into one of following cat-
egories: intact mitochondria with normal appearing cris-
tae (Type I); abnormal mitochondria with either swollen,
irregular, or whorling cristae (Type II); mitochondria with
discontinuous outer membrane or deficient cristae (Type
III); and mitochondria with both swollen and deficient
cristae or both discontinuous outer membrane and swol-
len cristae (Type IV) (for further details see Results). At
least 75 mitochondria were analyzed for each animal at
10 (n  3), 12 (n  3), 16 (n  3), and 18 (n  3) weeks
p.i. for both NBH- and ME7-animals, raw data per indi-
vidual animal have been expressed as percentage of
total number of mitochondria analyzed. The quantification
was performed blinded and the identities of the sections
and images were only revealed to the observer after the
data analysis was complete.
Immunohistochemistry
Coronal hippocampal sections (10 m) were cut from
formalin-fixed, paraffin-embedded brains, prepared as
described previously,19 the tissue was processed for
immunohistochemistry following citrate buffer and micro-
wave antigen retrieval. Nonspecific peroxidase activity
was eliminated by incubating sections in 1 ml H2O2/100
ml ethanol (1% H2O2) for 10 minutes. Sections were
incubated in a humid chamber for 90 minutes at room
temperature with the primary antibody, a mouse mono-
clonal to porin (human mitochondrial) (1:300; Invitrogen,
Paisley, UK, Molecular Probes). The mouse-on-mouse kit
(Vector Laboratories, Inc., Peterborough, UK) was used
according to the manufacturer’s instructions to minimize
any background staining. Sections were then incubated
with avidin-biotin complex (Vector Laboratories, Inc.):
0.05% diaminobenzidine hydrochloride was used as sub-
strate in the peroxidase reaction. Sections were counter-
stained with hematoxylin and dehydrated before mount-
ing in Depex.
Histochemistry (Complex IV Activity)
The complex IV activity was detected as described pre-
viously.20 Fresh frozen coronal sections through the dor-
sal hippocampus (8 m) were air dried for 30 minutes at
room temperature before incubation in COX medium (100
mmol/L cytochrome c, 4 mmol/L diaminobenzidine tetra-
hydrochloride, and 20 mg/ml catalase in 0.2 mol/L phos-
phate buffer, pH 7.0) at 37°C for 50 minutes. To detect
mitochondria that lack complex IV activity, the activity of
complex II, which would be unaffected by any mtDNA
deletions, was determined by incubating in succinate
dehydrogenase medium (130 mmol/L sodium succinate,
200 mmol/L phenazine methosulphate, 1 mmol/L sodium
azide, 1.5 mmol/L nitroblue tetrazolium in 0.2 mol/L phos-
phate buffer, pH 7.0) at 37°C for 40 minutes immediately
following the incubation in COX medium and washing
steps. Following histochemistry, the sections were dehy-
drated followed by Histoclear and mounted in Depex.
The density of staining corresponding to complex IV
activity was determined by monochrome pixel density
analysis of digitally captured images using ImageJ soft-
ware (U.S. National Institutes of Health, http://rsb.info.nih.
gov/ij/download.html, last accessed July 8, 2010).
Uniformly stained areas of stratum radiatum in the
hippocampus (avoiding unstained areas such as blood
vessels) and subgranular layers of lateral parietal asso-
ciated cortex were selected and density measurements
Mitochondria in Synaptic Degeneration 1413
AJP September 2010, Vol. 177, No. 3
were performed as described previously.15 The transmit-
tance of the stratum radiatum was expressed as a ratio
relative to the transmittance in the lateral parietal cortex
(layers IV–VI). At least four measurements obtained from
four different sections were included from at least three
animals per experimental group.
Complex IV activity in relation to mitochondrial proteins
expression in fresh frozen sections was determined using
a recently described novel method.21 In brief, the com-
plex IV histochemistry was performed as described
above: then immunocytochemistry with primary antibod-
ies binding to porin or subunits of complex IV [subunit-I
(COX-I) and subunit-II (COX-II)] and complex II (70 kDa)
(Cambridge Biosciences, Cambridge, UK) using the
Menapath X-cell Plus HRP Polmyer detection system (A.
Menari Diagonsitics, Wokingham, UK) with Vector SG
(gray precipitate) as the chromogen was performed on
the same section. Sections were dehydrated and
mounted as usual. Bright field images of the two chromo-
gens diaminobenzidine and Vector SG were obtained
using tuneable filters to acquire multispectral images
(Nuance imaging, CRi imaging, Woburn, CA). Deconvo-
lution methods were then used to unmix the two images,
which can then be quantified and pseudocolored.21
Dissection of Hippocampus
All dissection procedures were performed at 4°C. The
hippocampal formation was dissected out, and placed
on dry ice. Samples for biochemical analyses were ho-
mogenized in suspension buffer (2% SDS/25 mmol/L
HEPES/125 mmol/L KCL containing a mixture of phos-
phatase inhibitors and Complete protease inhibitor cock-
tail (Roche, UK). Samples were incubated on ice for 1
hour then centrifuged at 15,000 rpm for 30 minutes at
20°C. The supernatant was collected as the SDS soluble
fraction. Proteins were quantified using the Bio-Rad pro-
tein assay (Bio-Rad, Hercules, CA), solubilized in loading
buffer and analyzed by SDS-polyacrylamide gel electro-
phoresis and Western blotting according to standard
protocols.22 The hippocampal CA1 subregions used in
mtDNA studies were microdissected and stored at
80°C before DNA extraction.
Western Blot Procedure
Membranes were blocked in 5% nonfat milk for 1 hour at
room temperature and then incubated in Tris-buffered
saline containing 0.1% Tween-20 and monoclonal anti-
body against porin protein (1:4000; Invitrogen, Molecular
Probes). Membranes were incubated with the primary
antibody overnight at 4°C. The blots were washed and
incubated for 1 hour with fluorescently labeled anti-
mouse secondary antibody at room temperature. Protein
band intensities were analyzed using a LiCor Odyssey
infrared detection system following the manufacturer’s
guidelines, and normalized to total protein loading as
previously described.17
Statistical Analysis
The identities of the sections, images and samples were
only revealed to the observer after the data analysis was
complete. Raw data accumulated from every block were
collated using Microsoft Excel and appropriate statistical
tests were applied (indicated in Results section) to com-
pare final data between NBH- and ME7-animals using
Graph Pad Prism 4.0 (Graph Pad Software Inc., San
Diego, CA).
Results
The loss of synapses from the stratum radiatum of the
hippocampus is an early feature of the neuropathology in
experimental prion diseases, and precedes neuronal
loss.14,15,17 To detect possible changes in mitochondrial
density we used three different methods of analyzing
hippocampal tissue samples, a structure in which the
synaptic loss has already been documented, and com-
pared them with age-matched NBH-animals. Western
blot analysis of samples from dissected hippocampus
(n  4 animals/time point) (Figure 1A and B; Two-way
analysis of variance, Bonferroni posttests) revealed that
expression of porin protein, a mitochondrial outer mem-
brane marker, did not change significantly during disease
progression. Immunocytochemistry on brain sections pass-
ing through the dorsal hippocampus of NBH- and ME7-
animals (n  3 animals/time point) (Figure 2A) for porin
yielded no evidence of reduced mitochondrial density
consistent with the data from Western blots. However,
changes of the distribution of the porin protein were
apparent. For example, in NHB-animals the levels of
porin expression in the stratum oriens and the most prox-
imal stratum radiatum were denser than porin expression
in the stratum radiatum of the distal CA1 dendrites. This
differential laminar pattern was lost in both early (ME7 ES)
and late stage (ME7 LS) ME7-animals (Figure 2A). A
Figure 1. A: Western blot analysis of samples from dissected hippocampal
tissue from NBH- and ME7-animals at different stages of disease illustrate the
expression of porin protein (31-kDa band), a mitochondrial-specific protein
located in the outer mitochondrial membrane. B: Quantification of porin
expression (n  4/time point) in ME7-animals and age-matched NBH-
animals where porin levels are expressed relative to the total protein loaded
onto the gel and assayed by Licor Odessey detection system. No statistically
significant differences have been detected (two-way analysis of variance,
Bonferroni post-tests).
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progressive atrophy of the hippocampus, mainly affect-
ing the pyramidal cell and the stratum radiatum layers
was also observed in diseased tissue15 (Figure 2A).
We next analyzed the mitochondrial density within the
neuronal processes of the stratum radiatum as illustrated
in Figure 2B (upper panel). We have previously de-
scribed extensive and selective loss of Type I (excitatory)
synapses in the hippocampus,18 and from 12 weeks p.i.
and onwards dark degenerating synapses were present
in ME7-animals that were not detected in NBH-animals
(Figure 2B lower panel). In agreement with previous stud-
ies, mitochondria were rarely found in dendritic spines;23
approximately 10% of all presynaptic elements in the
CA1 region contained a mitochondrion both in NBH- and
ME7-animals. Among many hundreds of degenerating
synaptic boutons from 12 weeks onwards we have not
detected a mitochondrion present in the degenerating
terminal while its individual elements could still be re-
solved.18 These observations make it unlikely that the
mitochondria from the presynaptic elements degenerate
together with the synapses.
Although mitochondria are sparse within the hip-
pocampal astrocytic processes, the criteria used previ-
ously for identification of astrocytes and neuronal cells18
were applied to ensure that predominantly, if not exclu-
sively, neuronal mitochondria were included. As disease
progressed we observed a pronounced heterogeneity in
the mitochondrial morphology and the morphology of the
cristae in particular in all ME7-animals (Figure 3). In neu-
ronal processes, mitochondria appeared usually as
rodlets about 0.1 micron across and 1 micron long con-
taining longitudinally oriented, densely packed cristae. In
the few presynaptic terminals where we did detect mito-
chondria, they were small and globular in shape. Mito-
chondria with both normal and abnormal ultrastructural
appearance were present in diseased tissue and we
characterized them as follows: Type I - normal appearing
mitochondria with mostly longitudinally oriented and
tightly packed cristae (Figure 3A); Type II - abnormal
mitochondria with either swollen, irregular, or whorling
cristae in which the characteristic longitudinal orientation
and/or the tight and regular spacing of cristae were lost
or severely compromised (Figure 3B). At latter stages of
the disease we have detected increasing numbers of
mitochondria with a discontinuous outer membrane or
deficient cristae, in which the cristae order was distorted
by holes with an empty matrix—Type III (Figure 3C).
Finally, some mitochondria with swollen and deficient
Figure 2. A: Immunohistochemistry of fixed-brain sections reveals distribu-
tion and expression of porin in the neuropil of the stratum radiatum (ar-
rows) in both NBH- and ME7-animals. ES (early stage 12 to 13 weeks p.i.),
LS (late stage  19 weeks p.i.). Note the vacuolation and shrinkage of the
hippocampus in ME7-animals. Scale bars: 1.5 mm (first panel), 500 m
(second panel), and 200 m (third panel). B: Upper panel: electron micro-
graphs of the stratum radiatum neuropil illustrating mitochondrial population
in NBH- and ME7-animals at 18 weeks p.i. Examples of neuronal mitochon-
dria included in analysis are labeled bywhite asterisks and mitochondria in
non-neuronal cells by black asterisks, specifically in swollen astrocytic
processes (see Results for detailed description) in ME7 tissue. Note the
presence of whorling membrane fragments (arrow), frequently associated
with spongiform vacuolization in ME7-animals. Scale bars  5 m. Lower
panel: electron micrographs of the stratum radiatum neuropil illustrating
Type I (excitatory) synapses in NBH-animals and ME7-animals at 16 weeks
p.i. . Alterations of the synaptic morphology are evident in ME7-animals;
presynaptic terminals are filled with electron-dense cytoplasm, although still
visible, structurally compromised synaptic terminals are being enwrapped by
curved postsynaptic density specialization. Scale bars  1 m; 0.5 m
(insets).
Figure 3. Stratum radiatum neuropil, electron micrographs illustrating mito-
chondrial morphology in NBH-animals (A, Type I) at 18 weeks p.i. and repre-
sentative examples of mitochondria with abnormal morphology that frequently
appeared in ME7 animals at 16 (B, Type II) and 18 weeks (C, Type III; D, Type
IV) p.i. Scale bars: 1 m (A); 0.5 m (B); 1 m (C, D); and 1 m (all insets).
Arrows indicate the location of the images shown in the corresponding insets.
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cristae, or swollen cristae and discontinuous outer mem-
brane, Type IV, were present (Figure 3D).
Despite the frequent morphological abnormalities, the
density of neuronal mitochondria per unit area in the
stratum radiatum analyzed from electron micrographs at
10, 12, 16, and 18 weeks p.i. (Figure 4A) did not show
any significant changes (two-way analysis of variance,
Bonferroni post-tests). This ultrastructural quantitative
method confirmed our initial observations described
above (Figures 1 and 2A); not only were the mitochon-
drial counts similar in NBH-animals and at the onset of
synaptic loss (12 weeks p.i.) in ME7-animals, but surpris-
ingly the density was not significantly different at later
stages in ME7-animals (16 to 18 weeks p.i.).18
Ultrastructural integrity is a key indicator of mito-
chondrial function24 and mitochondrial swelling, gen-
erally reflected by an increase of the mitochondrial
area is a well-accepted hallmark of dysfunction of this
organelle.8,25 The mitochondrial area of at least 100 neu-
ronal mitochondria from the stratum radiatum (minimum
n  3 animal/time point) was measured. To achieve the
best representation possible, the same animals and sec-
tions were used as in density analysis described above.
Throughout disease progression no statistically signifi-
cant differences in mitochondrial area between NBH- and
ME7-animals were observed (Figure 4B; two-way analy-
sis of variance, Bonferroni post-tests), although at 18
weeks p.i. there is a trend for an increase of the area in
ME7-animals.
We next quantified the frequency of mitochondria with
ultrastructural changes in the inner membranes that we
described above. In NBH-animals the Type I mitochon-
dria (intact mitochondria with normal appearing cristae)
were predominantly represented; their percentage was
always significantly higher than any other types (Type
II–IV) (Figure 4C). In contrast to this, the proportions of
Type II–IV mitochondria (mitochondria with structural ab-
normalities) increased considerably at later stages (16
and 18 weeks p.i.) in all ME7-animals. In fact, when com-
pared with early stages (10 and 12 weeks p.i.) and NBH-
animals, individual categories of these abnormal mito-
chondria were no longer significantly different from the
pool of intact, normal appearing (Type I) mitochondria
(Figure 4C; two-way analysis of variance, Bonferroni
post-tests).
The findings described above provide evidence that
the mitochondrial inner membrane is ultrastructurally
compromised during the progression of prion disease.
We next wished to establish whether these changes are
reflected in the functional activity of the respiratory chain
complexes. We stained frozen tissue sections using en-
zyme histochemistry for COX (complex IV) and SDH
(complex II) activity, a widely used method for studying
mitochondrial function in other pathological and neuro-
pathological conditions, including Alzheimer’s dis-
ease.20,26,27,28 The pattern of the complex IV functional
activity in the control brains revealed a laminar distribu-
tion in the hippocampus, similar but not identical to the
distribution of porin protein. The levels of activity were
predominantly concentrated in the stratum oriens, lacuno-
sum moleculare layer, and in the most proximal and distal
parts of the CA1 dendrites in the stratum radiatum and in
the CA3 area. The assay indicated a decline in functional
activity of complex IV in the dorsal hippocampus of all
ME7-animals at 12 weeks p.i. (Figure 5, A and B) that
persisted in late stage of the disease (n  4 animals/time
point) (Figure 5, A and C).
Figure 4. A: Quantification of mitochondrial
density in neuronal processes of the stratum
radiatum of NBH- and ME7-animals. No statisti-
cally significant differences have been detected
(P  0.0819, two-way analysis of variance, Bon-
ferroni post-tests). B: Quantification of mean
mitochondrial area in neuronal population of
the stratum radiatum (at least 100 mitochondria
analyzed per animal [minimum n  3/time
point], two-way analysis of variance, Bonferroni
post-tests). C: Quantification of mitochondrial
structural defects in neuronal population of the
stratum radiatum in ME7- and NBH-animals (for
a more detailed description of the identification
criteria see Results). Percentages of intact mito-
chondria with normal appearing cristae (Type
I); abnormal mitochondria with either swollen,
irregular or whorling cristae (Type II); mito-
chondria with discontinuous outer membrane or
deficient cristae (Type III); and mitochondria
with both swollen and deficient cristae or both
discontinues outer membrane and swollen cris-
tae (Type IV) have been expressed from total
pool of all neuronal mitochondria in NBH- and
ME7-animals against disease stage (*P  0.05,
**P  0.01, ***P  0.005; two-way analysis of
variance, Bonferroni post-tests).
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On closer examination we observed that the laminar
distribution of the activity was altered, it was apparent
that in the CA1 pyramidal layer, the stratum radiatum and
the lacunosum moleculare layer of the hippocampus
there was a reduction in the intensity of the product
deposited due to the COX enzymatic reaction (Figure 6,
A–C). The CA3 area appeared to be unaffected at 12
weeks p.i. and maintained relatively high activity levels
even at the late stage when compared with other areas
within the hippocampus. We did not detect any blue
(COX-deficient, complex II or SDH-positive) elements ei-
ther within the pyramidal layer or the stratum radiatum
even in the late disease stage (Figure 6D). These findings
would suggest that the COX activity is reduced as quan-
tified by densitometry (Figure 6E; P  0.001 one-way
analysis of variance, Bonferroni post-tests) rather than
completely absent in ME7-animals and therefore does
not allow for generation of the blue product generally
observed in COX-deficient cells.
To further clarify whether the early alterations in COX
activity result from local mitochondrial loss of activity we
took advantage of a recently described method that al-
lowed us to assay and co-localize the COX activity in
relation to expression of mitochondrial proteins such as
porin and subunits of complex IV and complex II in the
same tissue section.21 Fresh frozen hippocampal sec-
tions from a control animal were stained consecutively
(Figure 7, A–D) for COX activity and mitochondrial pro-
teins. The activity was detected in neurons in CA1 and in
the adjacent neuropil in the stratum radiatum (brown in A,
pseudocoloured red in C). The porin expression (gray in
A, pseudocoloured green in D) almost completely over-
laps with the COX activity pattern as seen in the merged
image in Figure 7B. In contrast to this, sections from a
ME7-animal at 12 weeks p.i. (Figure 7, E–H) indicated
selective loss of COX activity in neurons and neuropil
(brown in E, pseudocoloured red in G) but comparable
levels of porin-positive mitochondria (gray in E, pseudo-
coloured green in H) to NBH-animals (D). The merge of
images G and H (Figure 7F) reveals porin positive mito-
chondria lacking COX activity. When quantified using
densitometry (Figure 7I), statistical analysis confirmed a
significant decline of COX activity both at early (12 weeks
p.i.) and late stage (18 weeks p.i.) that occurs indepen-
dently of mitochondrial loss (P 0.001, one-way analysis
of variance, Bonferroni post-tests). As not all mitochon-
dria labeled with porin showed COX activity, we deter-
mined activity relative to immunoreactivity of individual
Figure 5. Cytochrome c oxidase activity in
fresh coronal brain sections of a NBH (A); ME7
ES (early stage  12 to 13 weeks p.i.; B) and
ME7 LS (late stage  19 weeks p.i.; C) animals;
Hippocampal layers: Or-oriens, Py-pyramidal
Cell, Rad-stratum radiatum; LMol-lacunosum
moleculare layer; dentate gyrus layers: Mol-mo-
lecular, GrDG-granular layer. Scale bar  100
m. Note progressive loss of the distinct laminar
pattern (arrows, Rad and LMol layers) of COX
IV activity in the hippocampal formation of
ME7-animals.
Figure 6. A: Cytochrome c oxidase activity in fresh coronal brain sections of a NBH-animal at 18 weeks p.i.; (B) ME7 ES (ME7-animal, early stage  12 to 13
weeks p.i.); and (C) ME7 LS (ME7-animal, late stage  19 weeks p.i.). D: The absence of respiratory-deficient cells which would appear blue (COX-deficient,
complex II or SDH-positive) was demonstrated by COX/SDH assay at the late stage of the disease 19 weeks p.i. Hippocampal layers: Or-oriens, Py-pyramidal cell,
Rad-stratum radiatum; LMol-lacunosum moleculare layer; dentate gyrus layers: Mol-molecular, GrDG-granular layer. Scale bars  100 m. E: Changes in COX
activity in the stratum radiatum of NBH- and ME7-injected animals. The graph plots the ratio of stratum radiatum staining to lateral parietal associated cortex
staining against disease stage. Statistically significant reduction in the stratum radiatum of ME7 animals (*P  0.05, **P  0.01, ***P  0.005; one-way analysis of
variance, Bonferroni post-tests). Note that decrease of the COX activity (arrows, Rad, LMol, and Mol layers) correlates both spatially and temporally with initial
pathology of synapses in the stratum radiatum.17,18
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catalytic subunits because mitochondrial dysfunction
may be the result of modification, inhibition, or loss of
catalytic subunits. We thus examined, using the same
novel combined histochemical and immunocytochemis-
try technique, COX activity relative to catalytic subunits of
complex IV and subunit II. Interestingly, when corrected
for catalytic subunits of complex IV [subunit-I (COX-I) and
subunit-II (COX-II), P  0.0001 and P  0.0002 respec-
tively] and subunit of complex II (70 kDa) (P  0.0075) or
porin (P  0.0001), the COX activity in diseased animals
remained significantly reduced (one-way analysis of vari-
ance) (Table 1).
The accumulation of various mutations in the mitochon-
drial genome has been proposed as an important factor
contributing to aging and neurodegeneration and could
also underlie alteration of the COX activity.29,30 We next
screened mtDNA from microdissected CA1/stratum ra-
diatum regions for possible deletions. Freshly microdis-
sected tissue from six animals (n  3/treatment group) at
late stage (20 to 21 weeks p.i.) was used to isolate DNA
for amplification by PCR; similarly as described previ-
ously.31 No mtDNA deletions were detected on resolving
the amplified PCR product from both NBH- and ME7-
animals. A full-length fragment of 14.55 kb spanning the
major arc of the mitochondrial genome has been de-
tected as expected when no mtDNA deletions are
present (data not shown).
Discussion
Synaptic loss is a common component of various neuro-
degenerative diseases including prion disease; however,
the underlying mechanisms are not well understood.
Damage to mitochondria and/or their dysfunction are
frequently associated with these pathologies.8–10 A pos-
sible mitochondrial contribution to the prion pathology
has not been explored in any detail to date.
Our present study demonstrates that the regions of
synaptic loss in murine prion disease contain neuronal
Figure 7. Immunohistochemical detection of mitochondrial porin using biotin-free method following complex IV
histochemistry. Hippocampal sections passing through the CA1 pyramidal layer (arrows) and stratum radiatum of
a NBH-animal (A–D) and a ME7-animal (E–H) at 12 weeks p.i. were subjected to an experiment of complex IV
histochemistry (A, E) followed by porin immunohistochemistry using Menapath polymer detection system and
Vector SG (gray) as chromogen (for a detailed description see Materials and Methods). Unmixed complex IV
activity in red (C, G) and unmixed porin immunoreactivity in green (D, H) is illustrated by pseudocolored images.
The selective decrease of complex IV activity in ME7-animal is apparent in combined merged images of complex
IV histochemistry and porin immunohistochemistry (B, F). Statistically significant reduction of COX IV activity in
ME7 animals was revealed by densitometry (I) (*P  0.05, **P  0.01, ***P  0.005; one-way analysis of variance,
Bonferroni post-tests). The graph plots the ratio of pixel unit density between complex IV activity and porin
immunohistochemistry; ME7 ES (12 weeks p.i.) and ME7 LS (18 weeks p.i.). Scale bar  20 m.
Table 1. Relationship between COX Activity and
Immunoreactivity of Catalytic Subunits of Complex
IV, Complex II (70 kd) and Porin Protein
P value
ratio COX activity/Porin
NBH 0.9208  0.0104 0.0001
ES 0.6323  0.0064
LS 0.8392  0.0113
ratio COX activity/COX I
subunit
NBH 0.9704  0.0537 0.0001
ES 0.2434  0.0122
LS 0.4759  0.0290
ratio COX activity/COX II
subunit
NBH 1.0640  0.0789 0.0002
ES 0.7437  0.0379
LS 0.9362  0.0413
ratio COX activity/
Complex II (70 kd)
NBH 0.5363  0.1303 0.0075
ES 0.3346  0.0230
LS 0.4675  0.0370
COX activity relative to presence of mitochondria and catalytic
subunits of complex IV subunit-I (COX-I) and subunit-II (COX-II),
complex II and outer membrane marker (porin) was established by
enzyme histochemistry combined with immunohistochemistry on same
tissue section (for detailed description see Materials and Methods). The
activity to protein ratio was resolved using Nuance CRi system,
providing normalization across three distinct mitochondrial sub-
compartments. A reduction in ratio reflects a decrease in COX activity;
no significant change in densitometric values of porin and individual
subunits immunoreactivity was detected (*P  0.05, **P  0.01, ***P 
0.005; One-way ANOVA), ME7 ES (12 weeks p.i.) and ME7 LS (18
weeks p.i.).
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processes with abnormalities of the mitochondrial inner
membrane and mitochondria, in which the respiratory
complex IV function is impaired. However, no concomi-
tant reduction in the mitochondrial density has been de-
tected in contrast to early loss of the type I synaptic
density.18 Three independent quantitative methods led
us to conclude that no or a very minor, undetectable
change in mitochondria density occurs before (10 weeks
p.i.) or at the time of initiation of the synaptic pathology
(12 weeks p.i.). No significant increase of the mitochon-
dria with structural abnormalities was detected either
when compared with NBH-animals (12 weeks p.i.). A
profound neuronal loss occurs at late stage14,15 and
presumably also involves changes of absolute mitochon-
drial numbers. However, using our approaches we failed
to detect any such decline in mitochondrial density. The
likely explanation is that as the neurons atrophy and die,
the mitochondrial density per unit volume of neuropil
remains relatively constant.
In the CNS, dendritic spines, the predominant recipi-
ents of excitatory synaptic input are recognized as a
distinct biochemical compartment sufficient to provide
the capacity for signaling at individual synapses. In con-
trast to dendritic shafts, mitochondria are rarely observed
within dendritic spines of cortical or hippocampal neu-
rons: exceptions are restricted to large and complex
spines (“thorny excrescences”) of CA3 pyramidal neu-
rons.23,32 In agreement with these latter studies, we ob-
served the majority of mitochondria within dendritic shafts
and presynaptic terminals in NBH- and ME7-animals, and
only on a very few occasions were mitochondria present
in dendritic protrusions. The low frequency of dendritic
spines containing mitochondria in electron microscope
preparations is in accord with findings from cultured hip-
pocampal neurons.7 Several studies indicate that the
mitochondrial and synaptic functions in neuronal cells are
co-dependent and well be synchronized, mitochondria
can relocate to the compartment in which the activity and
energy demands increase.6,7 One possibility is that the
first abnormalities of synaptic function in ME7-animals33
could result in a reduction in or silencing of the mitochon-
drial function in response to decreased respiratory de-
mands and a subsequent retraction of mitochondria from
degenerating synaptic terminal to the remaining axonal
compartment. These observations would explain the ab-
sence of changes in the mitochondrial density at early
stages.18
As disease progressed we have encountered increas-
ing numbers of neuronal mitochondria containing various
morphological defects in the inner membrane morphol-
ogy. Sequential COX/SDH activity assay revealed that
these structural defects were accompanied with func-
tional impairment of the complex IV activity. There are
several possibilities for the impairment of the respiratory
function.
An altered organization of the inner mitochondrial
membrane may results in change of the mtDNA copy
number, as mtDNA nucleoids are anchored on the matrix
side of the inner membrane. We however considered this
possibility as unlikely due to no change in protein levels
encoded by mtDNA and distributed in all mitochondrial
subcompartments.
It is possible that a misfolded form of the PrPC could
interact with neuronal mitochondria in the neuropil and
interfere with their function, in a similar manner to that
reported in Alzheimer’s disease and its animal model.34
Both specific and non-specific interactions of the mis-
folded form could be influencing mitochondrial mem-
brane properties and function via intermediates such as
phospholipase A2 similar to A peptides.35 Aiken and
colleagues showed that mitochondria purified from
brains of scrapie-infected hamsters contained high infec-
tivity titers.36 However, unlike A peptide that interacts
with the mitochondria of Alzheimer’s disease patients and
transgenic mice, in this study prion protein failed to show
a significant association with these mitochondrial frac-
tions. In contrast, the mitochondrial localization of the
cellular prion protein PrPC has been implicated in neuro-
nal apoptosis in aged transgenic mice overexpressing
PrPC.37 Further research will be required to exclude the
possibility that misfolded PrPC does not directly interact
with any mitochondrial protein or bind to its membrane
nonspecifically.
On the other hand, astrogliosis as observed in a prion
disease38 can be accompanied by up-regulation of nitric
oxide as in various other pathologies.39,40 It is docu-
mented that nitric oxide is a potent mediator of brain
damage and may directly impair mitochondrial function41
by inhibiting the binding of oxygen to complex IV42 and
when over-expressed, may impair the activity of mito-
chondrial respiratory chain complexes I and IV.43,44 The
fact that the decrease in COX activity was still apparent
when normalized by measuring immunoreactivity of the
catalytic subunits indicates either inhibition or inactivation
of the complex as the most likely mechanism of mitochon-
drial dysfunction. The decrease in ratios was not due to a
significant increase in the densitometric values of mito-
chondrial proteins immunoreactivity (data not shown).
Although no significant increase in inducible-nitric ox-
ide synthase has been detected in prion diseased
brains,45,46 we have shown that in early stage disease
(12–13 weeks p.i.) there is a significant increase in neu-
ronal-nitric oxide synthase in the hippocampus.47 The
increase in neuronal-nitric oxide synthase occurs in the
stratum radiatum and declines in late disease stage con-
sistent with the changes in COX activity that we report
here. Thus the idea that nitric oxide could damage mito-
chondria in ME7-animals is justified. However, this could
go a step further because an increase in neuronal-nitric
oxide synthase has been shown to be directly associated
with neuronal injury and loss of synapses.48
In contrast to progressive deterioration of the mito-
chondrial ultrastructure in neuronal population, we gen-
erally did not observe any similar changes in other cell
types. Specifically, within astrocytic processes that are
frequently observed in degenerating hippocampal neu-
ropil, the sparsely distributed mitochondria appeared to
be normal.
Reduced mitochondrial numbers and altered morphol-
ogy of the inner mitochondrial membrane (loss of internal
structure with poorly defined and sparse cristae) were
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also observed in mice lacking PrPC. Mitochondria in hip-
pocampi of these normal appearing animals frequently
looked swollen, having significantly larger diameters
when compared with wild-type animals.49 Similar to a
previous study,50 we also detected neuronal mitochon-
dria with fewer, poorly defined and swollen cristae. The
inner membrane ultrastructure is an important parameter
used for determination of the mitochondrial respiration
capacity and is also the site where the reactive oxygen
species are constantly produced.51
As indicated by the morphology defects and the re-
duction in complex IV activity, the respiratory capacity of
neuronal mitochondria in prion disease could be compro-
mised early on and coincides with initiation of the synap-
tic loss. A misbalance in the reactive oxygen species
levels, among other changes, could be induced and this
could further exacerbate the ongoing pathology. Mito-
chondrial abnormalities at the onset of behavioral deficits
in ME7-induced murine prion disease are further con-
firmed by the observation that N-acetyl aspartate levels,
synthesized by neuronal mitochondria with intact metab-
olism,52 are decreased in the thalamus and hippocam-
pus, brain regions associated with early behavioral defi-
cits.53 Studies of respiration rate in PrP-null brain
mitochondria have yielded contradictory observations: a
complex I specific increase in superoxide formation has
been reported54 but normal mitochondrial respiration rate
was detected by others.55
Mutations of the mitochondrial genome accumulating
with age and in diseases such as cardiomyopathies or
Parkinson’s disease have been suggested to be the un-
derlying cause.26,56 We examined whether specific de-
crease of the COX activity could be rooted in alterations
of the mitochondrial genome, despite the fact that the
brain mitochondria have a relatively long half-life.57 As
expected, we found that the mtDNA from diseased ani-
mals was intact and we assume that it is not the under-
lying cause for functional abnormalities.
In conclusion, here we present observations that im-
plicate an overt mitochondria dysfunction in early patho-
genesis of the experimental murine prion disease that
could contribute to the disease progression. The intrigu-
ing mechanisms underlying the impairment of the mito-
chondrial function that could trigger and/or exacerbate
synaptic loss remain to be clarified.
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